These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 19838062)

  • 21. Upregulation of thioredoxin and its reductase attenuates arsenic trioxide‑induced growth suppression in human pulmonary artery smooth muscle cells by reducing oxidative stress.
    Park WH
    Oncol Rep; 2020 Jan; 43(1):358-367. PubMed ID: 31789420
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Auranofin induces mesothelioma cell death through oxidative stress and GSH depletion.
    You BR; Park WH
    Oncol Rep; 2016 Jan; 35(1):546-51. PubMed ID: 26530353
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synergistic targeting of TrxR1 and ATM/AKT pathway in human colon cancer cells.
    Shen X; Xia Y; Lu H; Zheng P; Wang J; Chen Y; Xu C; Qiu C; Zhang Y; Xiao Z; Zou P; Cui R; Ni D
    Biomed Pharmacother; 2024 May; 174():116507. PubMed ID: 38565059
    [TBL] [Abstract][Full Text] [Related]  

  • 24. RITA can induce cell death in p53-defective cells independently of p53 function via activation of JNK/SAPK and p38.
    Weilbacher A; Gutekunst M; Oren M; Aulitzky WE; van der Kuip H
    Cell Death Dis; 2014 Jul; 5(7):e1318. PubMed ID: 25010984
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selenocysteine induces apoptosis in human glioma cells: evidence for TrxR1-targeted inhibition and signaling crosstalk.
    Fan CD; Fu XY; Zhang ZY; Cao MZ; Sun JY; Yang MF; Fu XT; Zhao SJ; Shao LR; Zhang HF; Yang XY; Sun BL
    Sci Rep; 2017 Jul; 7(1):6465. PubMed ID: 28743999
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The p53-reactivating small-molecule RITA enhances cisplatin-induced cytotoxicity and apoptosis in head and neck cancer.
    Roh JL; Ko JH; Moon SJ; Ryu CH; Choi JY; Koch WM
    Cancer Lett; 2012 Dec; 325(1):35-41. PubMed ID: 22634494
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting p53 via JNK pathway: a novel role of RITA for apoptotic signaling in multiple myeloma.
    Saha MN; Jiang H; Yang Y; Zhu X; Wang X; Schimmer AD; Qiu L; Chang H
    PLoS One; 2012; 7(1):e30215. PubMed ID: 22276160
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhancement of auranofin-induced apoptosis in MCF-7 human breast cells by selenocystine, a synergistic inhibitor of thioredoxin reductase.
    Liu C; Liu Z; Li M; Li X; Wong YS; Ngai SM; Zheng W; Zhang Y; Chen T
    PLoS One; 2013; 8(1):e53945. PubMed ID: 23342042
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ethaselen synergizes with oxaliplatin in tumor growth inhibition by inducing ROS production and inhibiting TrxR1 activity in gastric cancer.
    Zhang H; Wu J; Yuan J; Li H; Zhang Y; Wu W; Chen W; Wang C; Meng S; Chen S; Huo M; He Y; Zhang C
    J Exp Clin Cancer Res; 2021 Aug; 40(1):260. PubMed ID: 34412665
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gambogic acid induces apoptosis in hepatocellular carcinoma SMMC-7721 cells by targeting cytosolic thioredoxin reductase.
    Duan D; Zhang B; Yao J; Liu Y; Sun J; Ge C; Peng S; Fang J
    Free Radic Biol Med; 2014 Apr; 69():15-25. PubMed ID: 24407164
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Auranofin, an inhibitor of thioredoxin reductase, induces apoptosis in hepatocellular carcinoma Hep3B cells by generation of reactive oxygen species.
    Hwang-Bo H; Jeong JW; Han MH; Park C; Hong SH; Kim GY; Moon SK; Cheong J; Kim WJ; Yoo YH; Choi YH
    Gen Physiol Biophys; 2017 Apr; 36(2):117-128. PubMed ID: 28218611
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sublethal concentrations of diverse gold compounds inhibit mammalian cytosolic thioredoxin reductase (TrxR1).
    Omata Y; Folan M; Shaw M; Messer RL; Lockwood PE; Hobbs D; Bouillaguet S; Sano H; Lewis JB; Wataha JC
    Toxicol In Vitro; 2006 Sep; 20(6):882-90. PubMed ID: 16510263
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thioredoxin reductase is required for the inactivation of tumor suppressor p53 and for apoptosis induced by endogenous electrophiles.
    Cassidy PB; Edes K; Nelson CC; Parsawar K; Fitzpatrick FA; Moos PJ
    Carcinogenesis; 2006 Dec; 27(12):2538-49. PubMed ID: 16777982
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potent inhibition of gastric cancer cells by a natural compound via inhibiting TrxR1 activity and activating ROS-mediated p38 MAPK pathway.
    He W; Cao P; Xia Y; Hong L; Zhang T; Shen X; Zheng P; Shen H; Zhao Y; Zou P
    Free Radic Res; 2019 Jan; 53(1):104-114. PubMed ID: 30668191
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inability of p53-reactivating compounds Nutlin-3 and RITA to overcome p53 resistance in tumor cells deficient in p53Ser46 phosphorylation.
    Ma T; Yamada S; Ichwan SJ; Iseki S; Ohtani K; Otsu M; Ikeda MA
    Biochem Biophys Res Commun; 2012 Jan; 417(3):931-7. PubMed ID: 22166212
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thimerosal, a competitive thioredoxin reductase 1 (TrxR1) inhibitor discovered via high-throughput screening.
    Ni Y; Luo Z; Lv Y; Ma S; Luo C; Du D
    Biochem Biophys Res Commun; 2023 Apr; 650():117-122. PubMed ID: 36780763
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RITA requires eIF2α-dependent modulation of mRNA translation for its anti-cancer activity.
    Ristau J; van Hoef V; Peuget S; Zhu J; Guan BJ; Liang S; Hatzoglou M; Topisirovic I; Selivanova G; Larsson O
    Cell Death Dis; 2019 Nov; 10(11):845. PubMed ID: 31699971
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Piperlongumine as a direct TrxR1 inhibitor with suppressive activity against gastric cancer.
    Zou P; Xia Y; Ji J; Chen W; Zhang J; Chen X; Rajamanickam V; Chen G; Wang Z; Chen L; Wang Y; Yang S; Liang G
    Cancer Lett; 2016 May; 375(1):114-126. PubMed ID: 26963494
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The p53-reactivating small molecule RITA induces senescence in head and neck cancer cells.
    Chuang HC; Yang LP; Fitzgerald AL; Osman A; Woo SH; Myers JN; Skinner HD
    PLoS One; 2014; 9(8):e104821. PubMed ID: 25119136
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Auranofin reveals therapeutic anticancer potential by triggering distinct molecular cell death mechanisms and innate immunity in mutant p53 non-small cell lung cancer.
    Freire Boullosa L; Van Loenhout J; Flieswasser T; De Waele J; Hermans C; Lambrechts H; Cuypers B; Laukens K; Bartholomeus E; Siozopoulou V; De Vos WH; Peeters M; Smits ELJ; Deben C
    Redox Biol; 2021 Jun; 42():101949. PubMed ID: 33812801
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.